Long-term efficacy and safety of sustained-release diltiazem in the treatment of hypertension.
The long-term efficacy and safety of sustained-release diltiazem (Tilazem; Parke-Davis) were evaluated. A total of 27 young, physically active patients with hypertension were followed up for 17 months. On a dosage of 90 mg twice daily, adequate blood pressure reduction was obtained in 23 patients (85%). No adverse effects were noted.
Myburgh
D P
DP
Department of Cardiology, Institute for Aviation Medicine, Verwoerdburg, Tvl.
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D003692:Delayed-Action Preparations; D004110:Diltiazem / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D013997:Time Factors
D003692:Delayed-Action Preparations; D004110:Diltiazem